KEW, Inc.
Founded 2011
Cambridge, United States
19 employees
Series B
Total: $32.87M
Biotechnology, Health and Wellness +1
Cambridge, United States
19 employees
Series B
Total: $32.87M
Biotechnology, Health and Wellness +1
General Information
Get notified when KEW, Inc. moves
Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.
Track KEW, Inc.
Get real-time alerts for funding, hiring, news, and 40+ signal types.
Start Tracking — FreeDiscover More
United States Market
Biotechnology
About KEW, Inc.
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | •••••• | 4 |
|
12 Jan 2015 |
| Venture Round | •••••• | 2 |
|
06 Feb 2014 |
KEW, Inc. Alternatives & Competitors
KEW, Inc. vs
ACT Genomics
Taiwan
Make Personalized Medicine Accessible To All.
Series Unknown
121 employees
Biotechnology, Health Care
KEW, Inc. vs
Varinos Inc.
Japan
Empowering Families with Precision Medicine: For a Future of Personalized Genomic Solutions
Series C
11 employees
KEW, Inc. vs
Genomenon, Inc
United States
Genomic intelligence for clinical diagnostics and precision medicine development
Series Unknown
151 employees
Developer Tools, Enterprise Software
FAQ About KEW, Inc.
KEW, Inc. is a comprehensive genomic profiling company, dedicated to revolutionizing cancer care by providing therapeutic options based on an individual patient’s tumor genetic profile with CANCERPLEX®, our flagship clinical product for identifying genetic variants and matching them with targeted th...
KEW, Inc. was founded in 2011.
KEW, Inc. is headquartered in Cambridge, United States.
KEW, Inc. operates in the following industries: Biotechnology, Health and Wellness, Medical Devices.
KEW, Inc. has approximately 19 employees.
KEW, Inc. has completed 2 funding rounds, raising a total of $32.87M. The latest funding stage is Series B.
Top alternatives and competitors to KEW, Inc. include ACT Genomics, Varinos Inc., Genomenon, Inc, genomiQa Pty Ltd, Farsight Genome Systems. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
KEW, Inc. and ACT Genomics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Don't just browse. Track.
Signal Tracker monitors KEW, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.